This is a reminder about six Grand Challenges requests-for-proposals (RFPs) that are currently still open. We encourage you to apply and to share this with others in your network who may be interested.
The following five RFPs will remain open until Tuesday, March 25th, at 11:30 AM Pacific Time — two weeks from today.
- Innovations for Gram-Negative Antibiotic Discovery: a collaboration among the Novo Nordisk Foundation, Wellcome, and the Gates Foundation.
- Accelerating Innovations to Address Heavy Menstrual Bleeding in Women in Low-Resource Settings
- Enhancing HIV and TB Diagnosis: Adjunct Technologies for Sample Collection and Processing
- Innovative Data and Modeling Approaches to Measure Women's Health
- Reducing the Burden of Preeclampsia
The following RFP will remain open until Saturday, May 31st, at 11:30 AM Pacific Time.
- Innovations for Exceptionally Low-Cost Monoclonal Antibody (mAb) Manufacturing: a partnership between the Gates Foundation and LifeArc.*
Read summaries of selected Grand Challenges grants, explore an interactive world map of projects across the Grand Challenges network, and sign up on the Grand Challenges website to receive email updates like this one.
